Ali Daneshmand, MPH, MD

Publications

• Published 4/29/2025

  Veerapaneni D, Arunachalam Sakthiyendran N, Du Y, Mallinger LA, Reinert A, Yeon Kim S, Nguyen C, Daneshmand A, Abdalkader M, Mohammed S, Dupuis J, Sheth KN, Gilmore EJ, Greer D, Ong CJ. Early Pupil Abnormality Frequency Predicts Poor Outcomes and Enhances International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Model Prognostication in Traumatic Brain Injury. Crit Care Explor. 2025 May 01; 7(5):e1257. PMID: 40299976.

  Read at: PubMed

• Published 2/19/2025

  Cobler-Lichter MJ, Suchdev K, Tatro H, Cascone A, Yang J, Weinberg J, Abdalkader MK, Dasenbrock HH, Ong CJ, Cervantes-Arslanian A, Greer D, Nguyen TN, Daneshmand A, Chung DY. Safety and Outcomes of Valproic Acid in Subarachnoid Hemorrhage Patients: A Retrospective Study. Clin Neuropharmacol. 2025 Mar-Apr 01; 48(2):43-50. PMID: 40035592.

  Read at: PubMed

• Published 11/26/2024

  Veerapaneni D, Sakthiyendran NA, Kim SY, Nguyen C, Daneshmand A, Abdalkader M, Mohammed S, Dupuis J, Sheth KN, Gilmore EJ, Greer D, Ong CJ. Pupil Abnormality Frequency in the First 72 Hours Improves IMPACT score in Traumatic Brain Injury. medRxiv. 2024 Nov 26. PMID: 39649617.

  Read at: PubMed

• Published 10/28/2024

  Dadu A, Ta M, Tustison NJ, Daneshmand A, Marek K, Singleton AB, Campbell RH, Nalls MA, Iwaki H, Avants B, Faghri F. Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging. medRxiv. 2024 Oct 28. PMID: 39574848.

  Read at: PubMed

• Published 9/10/2024

  Cobler-Lichter M, Suchdev K, Tatro H, Cascone A, Yang J, Weinberg J, Abdalkader MK, Dasenbrock HH, Ong CJ, Cervantes-Arslanian A, Greer D, Nguyen TN, Daneshmand A, Chung DY. Safety and Outcomes of Valproic Acid in Subarachnoid Hemorrhage Patients: A Retrospective Study. medRxiv. 2024 Sep 10. PMID: 39314927.

  Read at: PubMed

View All 41 Publications:   View Full Profile in BUMC